Mark Massaro
Stock Analyst at BTIG
(4.41)
# 256
Out of 4,829 analysts
138
Total ratings
52.1%
Success rate
16.77%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Initiates: Buy | $60 | $61.37 | -2.23% | 1 | Apr 21, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $8 → $9 | $9.03 | -0.33% | 5 | Dec 18, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $65 → $75 | $51.63 | +45.26% | 16 | Nov 26, 2024 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $3.84 | - | 8 | Sep 10, 2024 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Sell | $0.2 → $7 | $7.76 | -9.79% | 6 | Aug 23, 2024 | |
| PSNL Personalis | Maintains: Buy | $5.5 → $7 | $5.04 | +38.89% | 1 | Aug 16, 2024 | |
| ZTS Zoetis | Maintains: Buy | $220 → $225 | $159.27 | +41.27% | 2 | Aug 12, 2024 | |
| NTRA Natera | Maintains: Buy | $125 → $135 | $151.95 | -11.15% | 13 | Aug 9, 2024 | |
| AKYA Akoya Biosciences | Downgrades: Neutral | n/a | $1.10 | - | 3 | Aug 6, 2024 | |
| WGS GeneDx Holdings | Maintains: Buy | $35 → $45 | $59.14 | -23.91% | 4 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $50 | $41.72 | +19.85% | 2 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $491.70 | +17.96% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $8.05 | +160.87% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $2.36 | +239.70% | 3 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.96 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $1.87 | +327.81% | 8 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $2.93 | +173.13% | 2 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $30 | $16.81 | +78.47% | 4 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $5.71 | -12.43% | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $25 | $15.36 | +62.76% | 2 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.29 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3.5 | $1.13 | +209.73% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $2.87 | +3,384.32% | 1 | Nov 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.15 | - | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $75.76 | +295.99% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $56.75 | -11.89% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $176.96 | -36.71% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $245.73 | -32.85% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $36.36 | +120.02% | 9 | Sep 10, 2018 |
Tempus AI
Apr 21, 2025
Initiates: Buy
Price Target: $60
Current: $61.37
Upside: -2.23%
Adaptive Biotechnologies
Dec 18, 2024
Maintains: Buy
Price Target: $8 → $9
Current: $9.03
Upside: -0.33%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $65 → $75
Current: $51.63
Upside: +45.26%
Bionano Genomics
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.84
Upside: -
Ginkgo Bioworks Holdings
Aug 23, 2024
Maintains: Sell
Price Target: $0.2 → $7
Current: $7.76
Upside: -9.79%
Personalis
Aug 16, 2024
Maintains: Buy
Price Target: $5.5 → $7
Current: $5.04
Upside: +38.89%
Zoetis
Aug 12, 2024
Maintains: Buy
Price Target: $220 → $225
Current: $159.27
Upside: +41.27%
Natera
Aug 9, 2024
Maintains: Buy
Price Target: $125 → $135
Current: $151.95
Upside: -11.15%
Akoya Biosciences
Aug 6, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.10
Upside: -
GeneDx Holdings
Jul 31, 2024
Maintains: Buy
Price Target: $35 → $45
Current: $59.14
Upside: -23.91%
Jul 30, 2024
Maintains: Buy
Price Target: $45 → $50
Current: $41.72
Upside: +19.85%
Jul 25, 2024
Initiates: Buy
Price Target: $580
Current: $491.70
Upside: +17.96%
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $8.05
Upside: +160.87%
Mar 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $2.36
Upside: +239.70%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.96
Upside: -
Mar 7, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $1.87
Upside: +327.81%
Mar 6, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $2.93
Upside: +173.13%
Jun 15, 2023
Maintains: Buy
Price Target: $38 → $30
Current: $16.81
Upside: +78.47%
Mar 22, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $5.71
Upside: -12.43%
Feb 28, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $15.36
Upside: +62.76%
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.29
Upside: -
Nov 18, 2022
Maintains: Buy
Price Target: $5 → $3.5
Current: $1.13
Upside: +209.73%
Nov 30, 2020
Initiates: Buy
Price Target: $100
Current: $2.87
Upside: +3,384.32%
Oct 8, 2020
Initiates: Neutral
Price Target: n/a
Current: $0.15
Upside: -
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $75.76
Upside: +295.99%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $56.75
Upside: -11.89%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $176.96
Upside: -36.71%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $245.73
Upside: -32.85%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $36.36
Upside: +120.02%